IJNS Journal Club | Cystic Fibrosis Newborn Screening
the chairs
1st IJNS Journal Club
Cystic Fibrosis Newborn Screening
We invite you to join us for the IJNS Journal Club to discuss the article entitled "Cystic Fibrosis Newborn Screening: A Systematic Review-Driven Consensus Guideline from the United States Cystic Fibrosis Foundation." Early diagnosis and intervention play a pivotal role in managing cystic fibrosis. To help facilitate a more timely and equitable screening process for CF, the US Cystic Fibrosis Foundation convened a multidisciplinary group of experts to develop an evidence-based consensus guideline for CF newborn screening. This guideline is based on a systematic review that synthesizes the latest evidence and expert consensus to provide public health and clinical professionals with recommendations on newborn screening practices for cystic fibrosis.
Join us as we explore the recommendations from the article and discuss their implications for newborn screening practice. We will discuss IRT cutoffs, CFTR panels and sequencing, and communication strategies.
Date: 25 September 2025
Time: 5:00 PM CEST | 11:00 AM EDT
Webinar ID: 813 7026 9080
Webinar Secretariat: journal.webinar@mdpi.com
Meet the Event Chairs
Meet Our Speakers
Dr. Meghan E. McGarry
Department of Pediatrics, University of Washington School of Medicine, Seattle WA, USA, Center for Respiratory Biology and Therapeutics, Seattle Children’s Research Institute, Seattle WA, USA;
Dr. Meghan McGarry is a Pediatric Pulmonologist and Associate Professor of Pediatrics at the University of Washington and Seattle Children’s Hospital. She has formal training in clinical pharmacology, epidemiology, and clinical research. Dr. McGarry’s research focuses on addressing health disparities in cystic fibrosis, including CFTR variant panels used in diagnosis and newborn screening leading to missed diagnoses. Dr. McGarry’s mission is to improve health and quality of life for all children with cystic fibrosis through research, education, advocacy, and community engagement.
Ms. Karen S. Raraigh
Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore MD, USA;
Karen Raraigh, MGC, is an Assistant Professor of Genetic Medicine at Johns Hopkins University. She earned her Master’s in Genetic Counseling from the University of Maryland in 2008 and completed a Fulbright fellowship in Dublin, Ireland from 2008-2009. Her work has focused on genotype–phenotype correlations, patient and provider education, and engagement of genetic counselors with CF clinics. Ms. Raraigh co-leads the CFTR2 project and national efforts to advance CF-specific genetic counseling and professional collaboration in the field. She has contributed to the development of guidelines related to CF carrier screening, newborn screening, genetic counseling, and genetic testing, and is committed to the improvement of CF screening and care through research and education.
Sponsors and Partners
Organizer
The webinar was hosted via Zoom and required registation to attend. The full recording can be found below. In order to learn about future webinars, you can sign up to our newsletter by clicking "Subscribe" at the top of the page.
Advances in Cystic Fibrosis Newborn Screening: From Laboratory Testing to Diagnosis
Guest Editors: Prof. Dr. Susanna A. McColley and Dr. Marci K. Sontag